The overexpression of ASPM, which contributes to neurogenesis and cell proliferation, is an independent risk factor for early tumor recurrence regardless of p53 mutation status and poor prognosis of HCC (Lin et al., 2008). This evidence concerns the gene ASPM and hepatocellular carcinoma.